SCHEMBL7046245

SCHEMBL7046245

CC(=O)Oc1ccc(CC(=O)c2cc(OC(C)=O)c(OC(C)=O)c([N+](=O)[O-])c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.45
RAB9A P51151 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C19 P33261 1/20 0.42
ALDH1A1 P00352 4/20 0.39
MAPK1 P28482 3/20 0.39
LMNA P02545 3/20 0.39
HTT P42858 2/20 0.39
MAOA P21397 2/20 0.39
MAOB P27338 2/20 0.39
TOP1 P11387 2/20 0.38
MAPT P10636 3/20 0.37
GAA P10253 1/20 0.37
RAF1 P04049 1/20 0.37
HPGD P15428 1/20 0.37
GFER P55789 1/20 0.37
PAX8 Q06710 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7048480 0.89 TOP1 (0.42) NPC1RAB9ASMN1; SMN2KMT2AMEN1
SCHEMBL7363637 0.77 TPMT (0.56) RAB9AALDH1A1LMNATOP1MAPT
SCHEMBL7371498 0.75 VCAM1 (0.51) KMT2AMEN1CYP3A4ALDH1A1MAPK1
SCHEMBL7436807 0.75 TPMT (0.43) RAB9ASMN1; SMN2KMT2AMEN1ALDH1A1
SCHEMBL7049743 0.74 BCL9 (0.41) NPC1RAB9ASMN1; SMN2KMT2AMEN1
SCHEMBL11166903 0.74 MEN1 (0.41) SMN1; SMN2KMT2AMEN1ALDH1A1LMNA
SCHEMBL7373621 0.73 L3MBTL1 (0.48) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL9253473 0.73 LMNA (0.51) NPC1RAB9ASMN1; SMN2KMT2AMEN1
SCHEMBL8728378 0.72 KMT2A (0.42) NPC1RAB9ASMN1; SMN2KMT2AMEN1
SCHEMBL7282357 0.71 KMT2A (0.48) SMN1; SMN2KMT2AMEN1ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1010688-B1 Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them PORTELA & CA SA (PT) 2003-04-09 EP disclosed
US-6512136-B1 Hypotensive, antiedemic agents; gastrointestinal disorders; Parkinson*s disease treatment PORTELA & C.A., S.A. (PT) 2003-01-28 US disclosed
EP-1010688-A1 Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them Portela & Ca., S.A. (PT) 2000-06-21 EP disclosed